Tradestie Institutional Equity Comparison Engine

IONS vs BMRN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BMRN Overall Edge

BMRN Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BioMarin Pharmaceuticals Inc (BMRN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, IONS trades at 90.9x Forward P/E with -58.8% operating margin (+54.9% YoY revenue) versus BMRN at 9.1x Forward P/E and 16.3% operating margin (+32.0% YoY). In options structure, IONS sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against BMRN sits in CONSOLIDATION (17th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner BMRN
IONS 90.9x vs BMRN 9.1x Fwd P/E
Growth & Margin Winner BMRN
Op Margin -58.8% vs 16.3% ยท YoY +54.9% vs +32.0%
Momentum & Technical Winner BMRN
1Y -59.1% vs +7.6% ยท 52W Pos 2% vs 42%
Options & Structure Winner BMRN
BREAKDOWN (17th %ile IV) vs CONSOLIDATION (17th %ile IV)
IONS NASDAQ
Ionis Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$28.57
-1.7% 1D
Market Cap $4.7B
1M Return -33.48%
1Y Return -59.1%
Forward P/E 90.9x
Unified AI Score
63.9 / 100 BUY
Tech 60.0 Fund 63.0 Flow 73.0 Mom 55.0
BMRN NASDAQ
BioMarin Pharmaceuticals Inc
Pharmaceutical Preparations
$58.32
+1.9% 1D
Market Cap $11.0B
1M Return +6.66%
1Y Return +7.56%
Forward P/E 9.1x
Unified AI Score
52.6 / 100 HOLD
Tech 57.0 Fund 61.0 Flow 66.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IONS -59.1% BMRN +7.56% Spread: +66.66 pp (BMRN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period IONS Revenue BMRN Revenue IONS Op. Margin BMRN Op. Margin Margin Edge
FY2018 $600M $1.49B -10.2% -8.3% BMRN
FY2019 $1.12B $1.70B 32.6% -5.9% IONS
FY2020 $730M $1.86B -23.6% -2.3% BMRN
FY2021 $810M $1.85B -3.7% -4.5% IONS
FY2022 $590M $2.10B -69.8% 7.7% BMRN
FY2023 $790M $2.42B -44.9% 7.7% BMRN
FY2024 $710M $2.85B -67.4% 17.0% BMRN
FY2025 $940M $3.22B -40.4% 12.7% BMRN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IONS (2) vs BMRN (8)
Institutional Metric IONS BMRN Criterion Row Winner
Market Capitalization Scale $4.7B $11.0B Larger Scale BMRN
Trailing P/E Ratio Valuation 90.9x 8.8x Lower Multiple BMRN
Forward P/E Ratio Valuation 90.9x 9.1x Lower Multiple BMRN
Revenue Growth (YoY) Growth +54.9% +32.0% Higher Growth IONS
Operating Margin (TTM) Profitability -58.8% 16.3% Higher Margin BMRN
Net Profit Margin Profitability -56.9% -0.5% Higher Margin BMRN
Return on Equity (ROE) Capital Efficiency -108.0% -0.3% Higher ROE BMRN
52-Week Range Position Momentum 2% ($27โ€“$87) 42% ($49โ€“$71) Stronger Trend BMRN
Beta / 30D Volatility Risk Regime 0.18ฮฒ ยท 86% Vol 0.28ฮฒ ยท 31% Vol Lower Realized Risk BMRN
Unified Institutional Score Composite Signal 63.9 / 100 (BUY) 52.6 / 100 (HOLD) Higher Composite IONS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IONS vs BMRN Buy Guide
IONS BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live IONS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BMRN CONSOLIDATION
67d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live BMRN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IONS nor BMRN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.